Dr. Satiro De Oliveira has been working for many years fighting pediatric cancer, having started his career in Brazil working at a hospital exclusively dedicated to the treatment of children with cancer and blood diseases. After two years of full-time clinical work, De Oliveira realized that the cure of pediatric cancer only will come from continuous research, and decided to restart his career in the United States as a physician scientist.
Under the mentorship of Dr. Donald Kohn, De Oliveira developed protocols for gene transfer into human Hematopoietic Stem and Progenitor Cells (HSPC), in vitro differentiation of human HSPC and functional cell assays. His work has developed novel immunotherapy concepts of using modified HSPC for cancer immunotherapy.
De Oliveira’s research interests are:
- Immunotherapy of Leukemias and Lymphomas
- Biology of Hematopoietic Stem Cell Transplantation
- Immune Reconstitution after Hematopoietic Stem Cell Transplantation and primary immune deficiencies
Selected Cancer-Related Publications:
Rodrigues PC, Oliveira SN, Viana MB, Matsuda EI, Nowill AE, Brandalise SR, Yunes JA. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2007 Aug;49(2):133-8.
Weltman E, Salvajoli JV, Hanriot Rde M, Prisco FE, Oliveira SN, Cruz JC, Borges SR, Lagatta M, Wajsbrot DB. Radiotherapy for pancreatic cancer. [Article in Portuguese] Rev Assoc Med Bras. 2002 Apr-Jun;48(2):118-28.